Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615.
JAMA Intern Med. 2021.
PMID: 33080005
Free PMC article.
Clinical Trial.
Relationship between GFR and albuminuria in stage 1 hypertension.
Palatini P, Mos L, Ballerini P, Mazzer A, Saladini F, Bortolazzi A, Cozzio S, Casiglia E; HARVEST Investigators.
Palatini P, et al.
Clin J Am Soc Nephrol. 2013 Jan;8(1):59-66. doi: 10.2215/CJN.03470412. Epub 2012 Sep 27.
Clin J Am Soc Nephrol. 2013.
PMID: 23024161
Free PMC article.
Item in Clipboard
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP.
Lombardi AM, de Marinis GB, Scandellari R, Magalini F, Sansoni P, Ballerini PF, Vettore S, Candeo N, Marson P, De Silvestro G, Fabris F.
Lombardi AM, et al. Among authors: ballerini pf.
Thromb Res. 2010 Aug;126(2):e154-6. doi: 10.1016/j.thromres.2010.02.005. Epub 2010 Mar 1.
Thromb Res. 2010.
PMID: 20193960
No abstract available.
Item in Clipboard
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.
Corazzelli G, Capobianco G, Arcamone M, Ballerini PF, Iannitto E, Russo F, Frigeri F, Becchimanzi C, Marcacci G, De Chiara A, Pinto A.
Corazzelli G, et al. Among authors: ballerini pf.
Cancer Chemother Pharmacol. 2009 Oct;64(5):907-16. doi: 10.1007/s00280-009-0941-9. Epub 2009 Feb 15.
Cancer Chemother Pharmacol. 2009.
PMID: 19219604
Item in Clipboard
Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia.
Degan M, Rupolo M, Bo MD, Stefanon A, Bomben R, Zucchetto A, Canton E, Berretta M, Nanni P, Steffan A, Ballerini PF, Damiani D, Pucillo C, Attadia V, Colombatti A, Gattei V.
Degan M, et al. Among authors: ballerini pf.
Clin Lymphoma. 2004 Sep;5(2):123-6. doi: 10.3816/clm.2004.n.019.
Clin Lymphoma. 2004.
PMID: 15453928
Item in Clipboard
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
Degan M, Bomben R, Bo MD, Zucchetto A, Nanni P, Rupolo M, Steffan A, Attadia V, Ballerini PF, Damiani D, Pucillo C, Poeta GD, Colombatti A, Gattei V.
Degan M, et al. Among authors: ballerini pf.
Br J Haematol. 2004 Jul;126(1):29-42. doi: 10.1111/j.1365-2141.2004.04985.x.
Br J Haematol. 2004.
PMID: 15198729
Free article.
Item in Clipboard
Cite
Cite